drugset / Trial / NCT02885441

Treatment of Acute Pancreatitis With Ketorolac

NCT02885441

Phase 4 Terminated 56 enrolled Ilam University of Medical Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

Patients with acute pancreatitis will be randomly assigned in either study group to receive oral (injection) Ketorolac or the control group. In patients who cannot tolerate oral medications, ketorolac injection will be used.

Timeline

Start
2016-09
Primary completion
2019-02-01
Completion
2019-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 10 mg Oral

Indications